USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: BOEHRINGER INGELHEIM G.M.B.H.
Number of results: 100+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

88777372
03/29/2021

Toray Kabushiki Kaisha (Toray Industries, Inc.)
Mark: MIRALIVO S#:88777372

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG

88779979
03/25/2021

Yair Hoenig
Mark: SPIREA S#:88779979

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG

90142984
12/15/2020

Chemport, Inc.
Mark: MYCOMAX S#:90142984

Boehringer Ingelheim Vetmedica GmbH

88909914
09/29/2020

Merck Sharp & Dohme Corp.
S#:88909914

Boehringer Ingelheim International GmbH

91264575
09/03/2020

Boehringer Ingelheim International GmbH
Mark: LEXIC S#:88880423

UpToDate, Inc.
Mark: LEXICOMP S#:85255763 R#:4218700
Mark: LEXI-COMP S#:76207988 R#:2784663
Mark: LEXI-DRUGS S#:76441063 R#:2755650

91253958
01/31/2020

Boehringer Ingelheim International GmbH
Mark: LUMINEXT S#:79266173

Luminex Corporation
Mark: LUMINEX S#:75162119 R#:2243135
Mark: LUMINEX S#:77025198 R#:3267571

79270509
01/16/2020

Boehringer Ingelheim International GmbH
Mark: HARMONIO S#:79270509

Roche Molecular Systems, Inc.

79266173
12/19/2019

Boehringer Ingelheim International GmbH
Mark: LUMINEXT S#:79266173

Luminex Corporation

86965134
12/16/2019

Pfizer Inc.
Mark: MIRADENZ S#:86965134

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG

79238258
01/17/2019

Boehringer Ingelheim Vetmedica GmbH
Mark: ZIVUMAR S#:79238258

JAZZ PHARMACEUTICALS, INC.

79196626
05/22/2018

Boehringer Ingelheim International GmbH
Mark: INVIAPI S#:79196626

79196656
05/22/2018

Boehringer Ingelheim International GmbH
Mark: INBUILD S#:79196656

79196655
05/22/2018

Boehringer Ingelheim International GmbH
Mark: INGETHER S#:79196655

79196658
05/22/2018

Boehringer Ingelheim International GmbH
Mark: INPIRIQ S#:79196658

79196624
05/22/2018

Boehringer Ingelheim International GmbH
Mark: INBIND S#:79196624

79196626
05/22/2018

Boehringer Ingelheim International GmbH
Mark: INVIAPI S#:79196626

79196625
05/22/2018

Boehringer Ingelheim International GmbH
Mark: INDOUBLE S#:79196625

87571033
01/23/2018

La Jolla Pharmaceutical Company
Mark: GIOVIQ S#:87571033

Boehringer Ingelheim International GmbH

87569810
01/22/2018

United Therapeutics Corporation
Mark: SPIRESTA S#:87569810

Boehringer Ingelheim Pharma GmbH & Co. KG

79200117
12/22/2017

Boehringer Ingelheim International GmbH
S#:79200117

79192538
12/04/2017

Boehringer Ingelheim International GmbH
Mark: RE-SONANCE S#:79192538

91237307
10/18/2017

Intra-Cellular Therapies, Inc.
Mark: CAMLYRA S#:87334143

Boehringer Ingelheim International GmbH
Mark: SAMLYRA S#:79190967 R#:5111796

91237305
10/18/2017

Intra-Cellular Therapies, Inc.
Mark: CAMLYR S#:87334225

Boehringer Ingelheim International GmbH
Mark: SAMLYRA S#:79190967 R#:5111796

91237303
10/18/2017

Intra-Cellular Therapies, Inc.
Mark: CAPLYRA S#:87334173

Boehringer Ingelheim International GmbH
Mark: SAMLYRA S#:79190967 R#:5111796

87334143
07/20/2017

INTRA-CELLULAR THERAPIES, INC.
Mark: CAMLYRA S#:87334143

Boehringer Ingelheim International GmbH